Patient Safety: HHS Has Taken Steps to Address Unsafe Injection Practices, but More Action Is Needed.

Prescription Drug Monitoring Programs: Evidence-based Practices to Optimize Prescriber Use.

Philadelphia, PA: Pew Charitable Trusts and Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University; 2016.

Request for comments on the proposed measures and 2020 targets for the National Action Plan for Adverse Drug Event Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics.

Federal Register. Washington, DC: Office of Disease Prevention and Health Promotion, US Department of Health and Human Services. October 20, 2016;81:72594-72595.

Effect of US Drug Enforcement Administration's rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing.

Jones CM, Lurie PG, Throckmorton DC. JAMA Intern Med. 2016;176:399-402.

In Conversation With… Rosemary Gibson, MSc

Advocate Redi-Code+ blood glucose test strips by Diabetic Supply of Suncoast: recall—labeling error.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; June 11, 2014.

New HHS Data Shows Major Strides Made in Patient Safety, Leading to Improved Care and Savings.

Washington, DC: US Department of Health and Human Services; May 7, 2014.

Drug Shortages: FDA's Ability to Respond Should Be Strengthened.

Testimony before the Committee on Health, Education, Labor, and Pensions, US Senate. US Government Accountability Office. GAO-12-315T (December 15, 2011) (testimony of Marcia Crosse, PhD).

Injection practices among clinicians in United States health care settings.

Pugliese G, Gosnell C, Bartley JM, Robinson S. Am J Infect Control. 2010;38:789-798.

How valid is the ICD-9-CM based AHRQ Patient Safety Indicator for postoperative venous thromboembolism?

White RH, Sadeghi B, Tancredi DJ, et al. Med Care. 2009;47:1237-1243.

In Conversation with...Steven J. Spear, DBA, MS, MS

Council recommendation on patient safety, including the prevention and control of healthcare associated infections.

Council of the European Union (2009).

Medicare nonpayment, hospital falls, and unintended consequences.

Inouye SK, Brown CJ, Tinetti ME. N Engl J Med. 2009;360:2390-2393. 

Intentionally harmful violations and patient safety: the example of Harold Shipman.

Baker R, Hurwitz B. J R Soc Med. 2009;102:223-227.

Nosocomial infection, the Deficit Reduction Act, and incentives for hospitals.

Graves N, McGowan JE Jr. JAMA. 2008;300:1577-1579.

The wisdom and justice of not paying for "preventable complications."

Pronovost PJ, Goeschel CA, Wachter RM. JAMA. 2008;299:2197-2199.

Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses.

Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. JAMA Netw Open. 2019;2:e186007.

Patient Safety: Global Action on Patient Safety.

Executive Board EB144/29 144th session. Geneva, Switzerland: World Health Organization; December 12, 2018.

In patient safety efforts, pharmacists gain new prominence.

Gale R. Health Aff (Millwood). 2018;37:1726-1729.

Antibiotic shortages in pediatrics.

Banerjee R, Thurm CW, Fox ER, Hersh AL. Pediatrics. 2018;142:e20180858.

Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK.

Bjerre LM, Parlow S, de Launay D, et al. BMJ Open. 2018;8:e020150.